S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CMND Clearmind Medicine Inc

1.20

0.01 (0.84%)

Dec 20 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Clearmind Medicine (NASDAQ:CMND)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Clearmind Medicine Charts.

Clearmind Medicine (NASDAQ:CMND)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Clearmind Medicine Charts.

Clearmind Medicine Inc News

Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format
Monday 16 December 2024 (5 days ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Monday 9 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 6 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 20 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 10 October 2024 (2 months ago) • Edgar (US Regulatory)

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site
Thursday 10 October 2024 (2 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Monday 30 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 26 September 2024 (3 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Tuesday 24 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 16 September 2024 (3 months ago) • Edgar (US Regulatory)

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy
Monday 16 September 2024 (3 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 16 September 2024 (3 months ago) • Edgar (US Regulatory)

More Clearmind Medicine Inc News Articles

CyberFuels (PK)

Kraig Biocraft Laborator... (QB)

GBT Technologies (PK)

KULR Technology

AMC Entertainment

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions